Leonard S. Schleifer, Bd. Co-Chair, President & CEO at REGENERON PHARMACEUTICALS, INC. (REGN), sold 49,426 shares at $1015.28 ($50.2M) on 2024-06-11, disclosed to the SEC on 2024-06-13.
Scheduled sale ($50.2M) by Bd. Co-Chair, President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1015.28 | 7,321 | $7.4M | 14.8% |
| 2 | $1015.28 | 7,321 | $7.4M | 14.8% |
| 3 | $1016.04 | 1,743 | $1.8M | 3.5% |
| 4 | $1016.04 | 1,743 | $1.8M | 3.5% |
| 5 | $1015.30 | 14,879 | $15.1M | 30.1% |
| 6 | $1015.30 | 14,879 |
| $15.1M |
| 30.1% |
| 7 | $1016.62 | 270 | $274K | 0.5% |
| 8 | $1016.62 | 270 | $274K | 0.5% |
| 9 | $1025.27 | 1,000 | $1.0M | 2.0% |
| Total | $1015.56 avg | 49,426 | $50.2M | 100% |
| Filing → |
| REGN | SELL | 2024-05-15 | $70.1M | — | Filing → |
| REGN | SELL | 2022-04-07 | $10.1M | — | Filing → |
| REGN | SELL | 2022-04-04 | $4.1M | — | Filing → |